Lung adenocarcinoma with marked eosinophilia and Löffler endocarditis: clinical deterioration after treatment withdrawal

This lung cancer diagnosis at a glance

Subtype
Non-Small Cell Lung Cancer
Biomarkers
Markers supported lung adenocarcinoma with TTF-1 and Napsin-A positivity. Ki-67 ~30%; FGFR1 rearrangement not detected.
Sex
Male
Treatment
supportive care, anticoagulation, diuretics, bronchodilation, antibiotics and mechanical ventilation
Outcome
Setback / Progression

Treatment course, step by step

  1. Before referral: unspecified oral herbal therapy without improvement
  2. inpatient evaluation found marked eosinophilia, Löffler endocarditis with intracardiac thrombus, and left upper-lung mass; biopsy confirmed lung adenocarcinoma
  3. family declined corticosteroid therapy
  4. supportive cardiopulmonary treatment with recombinant human brain natriuretic peptide, furosemide, bumetanide, aminophylline, and rivaroxaban
  5. family discontinued further treatment after cancer confirmation and requested voluntary discharge
  6. March 2023 readmission with worse dyspnea, bilateral lower-limb edema, bilateral pleural effusions, bilateral pneumonia, and Acinetobacter baumannii infection
  7. broad-spectrum antibiotics, vasopressors, nutritional support, sputum suction, endotracheal intubation, and mechanical ventilation
  8. oxygen saturation remained unstable and hypotension progressed; family withdrew care and requested voluntary discharge.

What happened, in summary

This 75-year-old man developed bilateral leg swelling and shortness of breath with exertion in October 2022 but did not seek formal medical care at first. By January 2023, he had much worse exercise tolerance, difficulty breathing while lying flat, fatigue, low urine output, poor appetite, poor sleep, constipation, and reduced urine volume. After 2 weeks of herbal therapy without improvement, he was referred to a larger hospital. Blood tests showed marked leukocytosis and severe eosinophilia. NT-proBNP was very high, suggesting severe cardiac strain. Echocardiography showed endocardial thickening, intracardiac thrombus, and left atrial and ventricular enlargement, consistent with Löffler endocarditis. Chest CT showed a mass-like high-density shadow in the left upper lobe with bronchial cutoff. Lung biopsy found atypical nested cells consistent with non-small cell lung cancer, and immunohistochemistry supported lung adenocarcinoma: AE1/AE3, Vimentin, P63, P40, Napsin-A, and TTF-1 were positive, while Synaptophysin and CD56 were negative; Ki-67 was about 30%. His family declined corticosteroid therapy. Treatment focused on cardiopulmonary support, including recombinant human brain natriuretic peptide, diuretics, aminophylline, and rivaroxaban, but his condition did not improve. After cancer confirmation, the family stopped further treatment and requested discharge. In March 2023, he was readmitted with worsening dyspnea, leg swelling, increased bilateral pleural effusions, bilateral pneumonia, and Acinetobacter baumannii infection. Despite antibiotics, vasopressors, nutritional support, suctioning, intubation, and mechanical ventilation, oxygen saturation remained unstable and hypotension progressed. The family withdrew care and requested voluntary discharge. The case links 2 serious processes: lung adenocarcinoma and hypereosinophilic cardiac disease. The family declined steroid therapy and later cancer-directed care, so management remained supportive during a course marked by worsening respiratory failure and infection.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar lung cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more lung cancer stories